Sapanisertib in Combination With Fulvestrant in Women With Advanced or Metastatic Breast Cancer After Aromatase Inhibitor Therapy
Clinical trial NCT02756364 · COMPLETED
Trial details
- NCT number
- NCT02756364
- Sponsor
- Calithera Biosciences, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-28
- Primary completion
- 2019-11-25
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.